Literature DB >> 12957761

Variation of the platelet glycoprotein IIIa PI(A1/A2) allele frequencies in the three ethnic groups of Singapore.

Jimmy Lim1, Suman Lal, Kenneth C Ng, Kheng-Siang Ng, Nilmani Saha, Chew-Kiat Heng.   

Abstract

BACKGROUND: Polymorphisms of the glycoprotein IIIa receptor have been shown to be associated with differences in platelet aggregability. The PI(A2) variant of the polymorphism has been reported to be an inherited risk factor for acute coronary events. Although the allele frequency of this polymorphism is well documented in Caucasian populations, studies involving Asian Indians, Malays and Chinese are lacking. We studied 706 random male individuals to determine the genotypic distribution of this polymorphism in Singapore.
METHODS: Male subjects included in this study were drawn from those undergoing routine annual medical examinations offered by their employers. Venous blood was obtained from these patients after an overnight fast and from which genomic DNA was extracted. Genotyping was carried out by polymerase chain reaction (PCR) followed by digestion with restriction enzyme NciI. Personal and family medical history of the subjects were also taken.
RESULTS: The genotype distribution of the individuals studied was in accordance to a population at Hardy Weinberg equilibrium. The frequency of the PI(A2) allele was 0.1, 0.01 and 0.01 in the Indians, Malays and Chinese, respectively. The differences in frequencies of the PI(A2) variant are significant among different ethnic groups (P<0.001 for Indians vs. Chinese and Indians vs. Malays).
CONCLUSIONS: We observed a significantly higher frequency of the PI(A2) allele among Indians relative to the Chinese and Malays in Singapore. The effect of this genotype may partially explain the higher rate of ischaemic heart disease seen among Indians compared to the Chinese and Malay ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957761     DOI: 10.1016/s0167-5273(02)00567-3

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

Review 1.  The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis.

Authors:  Christopher N Floyd; Albert Ferro
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

2.  Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Anna M Kucharska-Newton; Keri L Monda; Stephen Campbell; Patrick T Bradshaw; Lynne E Wagenknecht; Eric Boerwinkle; Bruce A Wasserman; Gerardo Heiss
Journal:  Atherosclerosis       Date:  2011-02-02       Impact factor: 5.162

3.  The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis.

Authors:  Christopher N Floyd; Agnesa Mustafa; Albert Ferro
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

4.  Expression of the PlA2 allele of glycoprotein IIIa and its impact on platelet function.

Authors:  Christopher N Floyd; Albert Ferro; Timothy D Warner
Journal:  JRSM Cardiovasc Dis       Date:  2015-11-03

5.  Association among PlA1/A2 gene polymorphism, laboratory aspirin resistance and clinical outcomes in patients with coronary artery disease: An updated meta-analysis.

Authors:  Jing Wang; Jie Liu; Yaqing Zhou; Fei Wang; Ke Xu; Deyu Kong; Jianling Bai; Jun Chen; Xiaoxuan Gong; Haoyu Meng; Chunjian Li
Journal:  Sci Rep       Date:  2019-09-11       Impact factor: 4.379

6.  β3-integrin Leu33Pro gain of function variant does not modulate inflammatory activity in human derived macrophages in diabetes.

Authors:  Philipp Helmer; Ellen Damm; Stephan Schiekofer; Kirsten Roomp; Jochen G Schneider
Journal:  Int J Med Sci       Date:  2021-05-13       Impact factor: 3.738

7.  Identification of ITGA2B and ITGB3 Single-Nucleotide Polymorphisms and Their Influences on the Platelet Function.

Authors:  Qian Xiang; Shun-Dong Ji; Zhuo Zhang; Xia Zhao; Yi-Min Cui
Journal:  Biomed Res Int       Date:  2016-11-14       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.